PACIRA.COM: Keyword Density Checker

Total words: 1445 | 2-word phrases: 378 | 3-word phrases: 405 | 4-word phrases: 419

PAGE INFO

Title	Try to keep the title under 60 characters (13 characters) Home \| Pacira
Description	Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (87 characters) We’re driving innovation to provide better ways to safely and effectively manage pain

#	Keyword	Frequency	Density
1	learn more	4	1.06%
2	exparel® bupivacaine	4	1.06%
3	bupivacaine liposome	4	1.06%
4	liposome injectable	4	1.06%
5	pmvl technology	4	1.06%
6	liposome pmvl	4	1.06%
7	injectable suspension	4	1.06%
8	multivesicular liposome	4	1.06%
9	is a	4	1.06%
10	close button	3	0.79%
11	a nonopioid	3	0.79%
12	extendedrelease injectable	3	0.79%
13	more close	3	0.79%
14	in the	3	0.79%
15	acetonide extendedrelease	3	0.79%
16	of the	3	0.79%
17	triamcinolone acetonide	3	0.79%
18	zilretta® triamcinolone	2	0.53%
19	the nerve	2	0.53%
20	knee pain	2	0.53%

#	Keyword	Frequency	Density
1	exparel® bupivacaine liposome	4	0.99%
2	bupivacaine liposome injectable	4	0.99%
3	liposome pmvl technology	4	0.99%
4	multivesicular liposome pmvl	4	0.99%
5	more close button	3	0.74%
6	triamcinolone acetonide extendedrelease	3	0.74%
7	acetonide extendedrelease injectable	3	0.74%
8	liposome injectable suspension	3	0.74%
9	advancing patient care	2	0.49%
10	of pacira biosciences	2	0.49%
11	zilretta® triamcinolone acetonide	2	0.49%
12	oa knee pain	2	0.49%
13	proprietary multivesicular liposome	2	0.49%
14	learn more close	2	0.49%
15	is a nonopioid	2	0.49%
16	cases longer as	1	0.25%
17	to transmit a	1	0.25%
18	regenerates over time	1	0.25%
19	over time the	1	0.25%
20	pain signal results	1	0.25%
21	a pain signal	1	0.25%
22	transmit a pain	1	0.25%
23	iovera° system offers	1	0.25%
24	ability to transmit	1	0.25%
25	nerve regenerates over	1	0.25%
26	system offers a	1	0.25%
27	interrupting the nerve’s	1	0.25%
28	nerves interrupting the	1	0.25%
29	targeted nerves interrupting	1	0.25%
30	to targeted nerves	1	0.25%

#	Keyword	Frequency	Density
1	exparel® bupivacaine liposome injectable	4	0.95%
2	multivesicular liposome pmvl technology	4	0.95%
3	triamcinolone acetonide extendedrelease injectable	3	0.72%
4	bupivacaine liposome injectable suspension	3	0.72%
5	proprietary multivesicular liposome pmvl	2	0.48%
6	learn more close button	2	0.48%
7	zilretta® triamcinolone acetonide extendedrelease	2	0.48%
8	cryoanalgesia device used to	1	0.24%
9	targeted nerves interrupting the	1	0.24%
10	system is an fdaapproved	1	0.24%
11	handheld cryoanalgesia device used	1	0.24%
12	ability to transmit a	1	0.24%
13	nerves interrupting the nerve’s	1	0.24%
14	only to targeted nerves	1	0.24%
15	to targeted nerves interrupting	1	0.24%
16	device used to deliver	1	0.24%
17	temperature only to targeted	1	0.24%
18	to transmit a pain	1	0.24%
19	of cold temperature only	1	0.24%
20	deliver precise controlled doses	1	0.24%
21	to deliver precise controlled	1	0.24%
22	used to deliver precise	1	0.24%
23	cold temperature only to	1	0.24%
24	skip to main content	1	0.24%
25	transmit a pain signal	1	0.24%
26	relief that can last	1	0.24%
27	as the nerve regenerates	1	0.24%
28	longer as the nerve	1	0.24%
29	cases longer as the	1	0.24%
30	some cases longer as	1	0.24%
31	in some cases longer	1	0.24%
32	and in some cases	1	0.24%
33	can last three months	1	0.24%
34	that can last three	1	0.24%
35	pain relief that can	1	0.24%
36	our iovera° system is	1	0.24%
37	with pain relief that	1	0.24%
38	treatment with pain relief	1	0.24%
39	iovera° treatment with pain	1	0.24%
40	after iovera° treatment with	1	0.24%